Details for Patent: 9,750,785
✉ Email this page to a colleague
Which drugs does patent 9,750,785 protect, and when does it expire?
Patent 9,750,785 protects VASOSTRICT and is included in one NDA.
Summary for Patent: 9,750,785
| Title: | Vasopressin formulations for use in treatment of hypotension |
| Abstract: | Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations. |
| Inventor(s): | Kenney; Matthew (New Haven, MI), Kannan; Vinayagam (Rochester, MI), Vandse; Sunil (Basking Ridge, NJ), Sanghvi; Suketu (Kendall Park, NJ) |
| Assignee: | PAR PHARMACEUTICAL, INC. (Chestnut Ridge, NY) |
| Application Number: | 15/426,703 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,750,785 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Device; Dosage form; |
Drugs Protected by US Patent 9,750,785
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Sterile Products | VASOSTRICT | vasopressin | SOLUTION;INTRAVENOUS | 204485-001 | Apr 17, 2014 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Par Sterile Products | VASOSTRICT | vasopressin | SOLUTION;INTRAVENOUS | 204485-002 | Dec 17, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
